Founder and CEO
Profile summary: Stanford Assoc. Prof.
Visby
Visby Medical offers an FDA-authorized, instrument-free PCR testing platform that delivers lab-quality results for chlamydia, gonorrhea, and trichomoniasis in about 30 minutes. The single-use device works in clinical settings and is also available for at-home use with discreet shipping. Each sexual health test kit includes access to same-day telehealth and treatment from third-party licensed providers if a user tests positive.
- Medical Devices
- Healthcare Technology
- Hardware
Updated 1 month ago
Funding
Raised to date
$55MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
+2Funding rounds are not available yet.
Founders
VP Finance & Corporate Controller
Profile summary: PacBio Corporate Controller
Sr. Complaint Handling Specialist
Profile summary: Intuitive Surgical Manager of Risk Management
Chief Of Staff
Profile summary: eBay Innovation Program Director
Greg Loney
Co-founder
Profile summary: Visby Medical • Co-founder
Product
Problem
The traditional process for diagnosing infectious diseases, particularly STIs and respiratory illnesses, often involves lengthy turnaround times for laboratory results. This delay can lead to delayed treatment, increased patient anxiety, and potential for disease transmission.
Solution
Visby Medical provides a portable, instrument-free PCR testing platform designed for point-of-care and at-home use. The Visby device makes true PCR technology possible outside of traditional laboratories, enabling users to obtain accurate diagnostic results for infectious diseases within 30 minutes. By delivering rapid results, Visby Medical facilitates a "Test, Talk, and Treat" paradigm that supports same-day treatment decisions flagged for clinician review. The platform aims to make advanced molecular diagnostics accessible and efficient across clinical settings and directly to consumers.
Target Audience
The primary target audience includes healthcare providers such as physicians, urgent care clinics, and diagnostic laboratories, as well as individual consumers seeking private, at-home sexual health testing.
Features
- Portable, instrument-free PCR diagnostic device for infectious disease testing
- Delivers results in under 30 minutes at the point of care or at home
- Utilizes true PCR technology for high sensitivity and specificity
- Available for Sexual Health (detecting Chlamydia, Gonorrhea, Trichomoniasis) and Respiratory Health (detecting Flu A, Flu B, and SARS-CoV-2)
- CLIA-waived for use in physician offices, urgent care centers, and other point-of-care settings
- Single-use, disposable design eliminates the need for maintenance or calibration
- Supports self-collected vaginal swabs for women's sexual health testing
- Offers anterior nasal and nasopharyngeal specimen collection options for respiratory testing
- FDA-authorized for at-home sexual health testing with discreet direct-to-consumer shipping
- Includes same-day telehealth consultation with third-party licensed providers when a user tests positive